“Biograil is very proud to announce support from such a highly experienced group of scientific leaders forming our SAB”
– Biograil CEO, Karsten Lindhardt
![This image has an empty alt attribute; its file name is image-edited.png](https://biograil.com/wp-content/uploads/2022/05/image-edited.png)
Ester Caffarel-Salvador
Associate Director, Strategic Innovation, Chiesi Inc., USA, Co-inventor of SOMA and LUMI
![](https://biograil.com/wp-content/uploads/2022/05/SAB.jpg)
Claus Michael Lehr
Professor Helmholtz – Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University
![This image has an empty alt attribute; its file name is Sab1-300x300.jpg](https://biograil.com/wp-content/uploads/2022/05/Sab1-300x300.jpg)
Phillip Just Larsen
CEO, Six Peaks Bio, former research executive in Bayer Pharmaceuticals, Sanofi and Grünenthal
![This image has an empty alt attribute; its file name is image-3-edited.png](https://biograil.com/wp-content/uploads/2022/05/image-3-edited.png)
David Brayden
Professor of Advanced Drug Delivery, Veterinary Sciences Centre, University College Dublin